BioCentury
ARTICLE | Company News

Vestar Inc. sales and marketing update

October 25, 1993 7:00 AM UTC

Vestar Inc. (VSTR) VSTR's AmBisome posted product sales of $7.8 million in the third quarter ended Sept. 30 compared to $7.2 million in the third quarter last year. VSTR said sales of the antifungal ...